Major HIV/AIDS Advances Led by the BC-CfE

  • BC-CfE unveils results of the INCAS trial, demonstrating HAART’s remarkable suppression of HIV
  • BC-CfE plays a key role in organizing the XI International AIDS Conference in Vancouver
  • Viral load testing is introduced to monitor disease progression and response to HAART

Leave a Reply

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025